Annual Working Capital
$952.20 M
+$36.40 M+3.97%
31 December 2023
Summary:
Neurocrine Biosciences annual working capital is currently $952.20 million, with the most recent change of +$36.40 million (+3.97%) on 31 December 2023. During the last 3 years, it has risen by +$122.50 million (+14.76%). NBIX annual working capital is now at all-time high.NBIX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$1.45 B
+$175.60 M+13.81%
30 September 2024
Summary:
Neurocrine Biosciences quarterly working capital is currently $1.45 billion, with the most recent change of +$175.60 million (+13.81%) on 30 September 2024. Over the past year, it has increased by +$488.60 million (+50.99%). NBIX quarterly working capital is now at all-time high.NBIX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | +51.0% |
| 3 y3 years | +14.8% | +85.5% |
| 5 y5 years | +46.6% | +105.7% |
NBIX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +31.0% | at high | +100.8% |
| 5 y | 5 years | at high | +258.4% | at high | +444.6% |
| alltime | all time | at high | +2587.9% | at high | +6867.3% |
Neurocrine Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.45 B(+13.8%) |
| June 2024 | - | $1.27 B(+17.1%) |
| Mar 2024 | - | $1.09 B(+14.1%) |
| Dec 2023 | $952.20 M(+4.0%) | $952.20 M(-0.6%) |
| Sept 2023 | - | $958.30 M(+4.8%) |
| June 2023 | - | $914.10 M(-13.7%) |
| Mar 2023 | - | $1.06 B(+15.6%) |
| Dec 2022 | $915.80 M(+26.0%) | $915.80 M(+27.1%) |
| Sept 2022 | - | $720.40 M(-1.8%) |
| June 2022 | - | $733.60 M(-4.1%) |
| Mar 2022 | - | $764.70 M(+5.2%) |
| Dec 2021 | $727.00 M(-12.4%) | $727.00 M(-6.8%) |
| Sept 2021 | - | $779.80 M(-13.1%) |
| June 2021 | - | $897.20 M(+0.2%) |
| Mar 2021 | - | $895.40 M(+7.9%) |
| Dec 2020 | $829.70 M(+212.3%) | $829.70 M(+52.0%) |
| Sept 2020 | - | $545.90 M(-4.8%) |
| June 2020 | - | $573.20 M(-30.8%) |
| Mar 2020 | - | $827.90 M(+211.6%) |
| Dec 2019 | $265.70 M(-59.1%) | $265.70 M(-62.2%) |
| Sept 2019 | - | $703.58 M(+8.5%) |
| June 2019 | - | $648.22 M(+15.5%) |
| Mar 2019 | - | $561.19 M(-13.6%) |
| Dec 2018 | $649.54 M(+29.8%) | $649.54 M(+151.8%) |
| Sept 2018 | - | $257.99 M(-49.0%) |
| June 2018 | - | $505.92 M(+8.3%) |
| Mar 2018 | - | $467.25 M(-6.6%) |
| Dec 2017 | $500.49 M(+78.7%) | $500.49 M(-1.9%) |
| Sept 2017 | - | $510.34 M(+0.3%) |
| June 2017 | - | $509.03 M(+135.8%) |
| Mar 2017 | - | $215.89 M(-22.9%) |
| Dec 2016 | $280.03 M(-21.9%) | $280.03 M(-15.5%) |
| Sept 2016 | - | $331.23 M(-9.3%) |
| June 2016 | - | $365.07 M(-3.3%) |
| Mar 2016 | - | $377.71 M(+5.4%) |
| Dec 2015 | $358.36 M(+96.3%) | $358.36 M(-1.3%) |
| Sept 2015 | - | $362.96 M(-2.4%) |
| June 2015 | - | $371.86 M(-4.6%) |
| Mar 2015 | - | $389.77 M(+113.5%) |
| Dec 2014 | $182.54 M(+33.5%) | $182.54 M(+7.5%) |
| Sept 2014 | - | $169.82 M(-8.5%) |
| June 2014 | - | $185.52 M(-12.1%) |
| Mar 2014 | - | $211.13 M(+54.4%) |
| Dec 2013 | $136.76 M(-21.2%) | $136.76 M(-6.3%) |
| Sept 2013 | - | $145.90 M(+3.3%) |
| June 2013 | - | $141.28 M(-3.6%) |
| Mar 2013 | - | $146.52 M(-15.6%) |
| Dec 2012 | $173.62 M(+103.4%) | $173.62 M(+12.1%) |
| Sept 2012 | - | $154.91 M(+1.8%) |
| June 2012 | - | $152.11 M(+2.5%) |
| Mar 2012 | - | $148.34 M(+73.8%) |
| Dec 2011 | $85.37 M(+6.3%) | $85.37 M(-2.6%) |
| Sept 2011 | - | $87.68 M(+25.2%) |
| June 2011 | - | $70.05 M(-9.7%) |
| Mar 2011 | - | $77.56 M(-3.4%) |
| Dec 2010 | $80.27 M | $80.27 M(+2.4%) |
| Sept 2010 | - | $78.41 M(-14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $91.64 M(+84.4%) |
| Mar 2010 | - | $49.70 M(+40.3%) |
| Dec 2009 | $35.43 M(-36.0%) | $35.43 M(+3.7%) |
| Sept 2009 | - | $34.15 M(+64.4%) |
| June 2009 | - | $20.77 M(-40.1%) |
| Mar 2009 | - | $34.67 M(-37.3%) |
| Dec 2008 | $55.33 M(-63.8%) | $55.33 M(-30.7%) |
| Sept 2008 | - | $79.83 M(-15.2%) |
| June 2008 | - | $94.14 M(-29.9%) |
| Mar 2008 | - | $134.23 M(-12.3%) |
| Dec 2007 | $153.04 M(-11.8%) | $153.04 M(+41.5%) |
| Sept 2007 | - | $108.16 M(-17.8%) |
| June 2007 | - | $131.65 M(-13.7%) |
| Mar 2007 | - | $152.49 M(-12.1%) |
| Dec 2006 | $173.54 M(-29.3%) | $173.54 M(-5.4%) |
| Sept 2006 | - | $183.51 M(-15.3%) |
| June 2006 | - | $216.69 M(-10.4%) |
| Mar 2006 | - | $241.97 M(-1.5%) |
| Dec 2005 | $245.62 M(-3.4%) | $245.62 M(-6.5%) |
| Sept 2005 | - | $262.59 M(+13.6%) |
| June 2005 | - | $231.23 M(-1.1%) |
| Mar 2005 | - | $233.85 M(-8.0%) |
| Dec 2004 | $254.23 M(-29.7%) | $254.23 M(-3.9%) |
| Sept 2004 | - | $264.55 M(-1.5%) |
| June 2004 | - | $268.55 M(-5.5%) |
| Mar 2004 | - | $284.11 M(-21.5%) |
| Dec 2003 | $361.80 M(+67.8%) | $361.80 M(+3.6%) |
| Sept 2003 | - | $349.10 M(+64.1%) |
| June 2003 | - | $212.69 M(-13.1%) |
| Mar 2003 | - | $244.72 M(+13.5%) |
| Dec 2002 | $215.62 M(-29.7%) | $215.62 M(-14.3%) |
| Sept 2002 | - | $251.51 M(-7.2%) |
| June 2002 | - | $270.97 M(-6.5%) |
| Mar 2002 | - | $289.95 M(-5.5%) |
| Dec 2001 | $306.75 M(+94.8%) | $306.75 M(+118.7%) |
| Sept 2001 | - | $140.26 M(+3.1%) |
| June 2001 | - | $135.99 M(-7.4%) |
| Mar 2001 | - | $146.79 M(-6.8%) |
| Dec 2000 | $157.45 M(+82.7%) | $157.45 M(+117.9%) |
| Sept 2000 | - | $72.24 M(-5.0%) |
| June 2000 | - | $76.03 M(-7.4%) |
| Mar 2000 | - | $82.09 M(-4.8%) |
| Dec 1999 | $86.20 M(+43.7%) | $86.20 M(+75.2%) |
| Sept 1999 | - | $49.20 M(-6.8%) |
| June 1999 | - | $52.80 M(-6.9%) |
| Mar 1999 | - | $56.70 M(-5.5%) |
| Dec 1998 | $60.00 M(-13.5%) | $60.00 M(-4.5%) |
| Sept 1998 | - | $62.80 M(-0.5%) |
| June 1998 | - | $63.10 M(-7.6%) |
| Mar 1998 | - | $68.30 M(-1.6%) |
| Dec 1997 | $69.40 M(+2.1%) | $69.40 M(+1.8%) |
| Sept 1997 | - | $68.20 M(+1.6%) |
| June 1997 | - | $67.10 M(-6.5%) |
| Mar 1997 | - | $71.80 M(+5.6%) |
| Dec 1996 | $68.00 M | $68.00 M(+6.9%) |
| Sept 1996 | - | $63.60 M(-2.2%) |
| June 1996 | - | $65.00 M(+199.5%) |
| Mar 1996 | - | $21.70 M |
FAQ
- What is Neurocrine Biosciences annual working capital?
- What is the all time high annual working capital for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual working capital year-on-year change?
- What is Neurocrine Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly working capital year-on-year change?
What is Neurocrine Biosciences annual working capital?
The current annual working capital of NBIX is $952.20 M
What is the all time high annual working capital for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual working capital is $952.20 M
What is Neurocrine Biosciences annual working capital year-on-year change?
Over the past year, NBIX annual working capital has changed by +$36.40 M (+3.97%)
What is Neurocrine Biosciences quarterly working capital?
The current quarterly working capital of NBIX is $1.45 B
What is the all time high quarterly working capital for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly working capital is $1.45 B
What is Neurocrine Biosciences quarterly working capital year-on-year change?
Over the past year, NBIX quarterly working capital has changed by +$488.60 M (+50.99%)